Multiple mechanisms of telomere maintenance exist in liposarcomas

被引:53
作者
Johnson, JE
Varkonyi, RJ
Schwalm, J
Cragle, R
Klein-Szanto, A
Patchefsky, A
Cukierman, E
von Mehren, M
Broccoli, D
机构
[1] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA
[3] Fox Chase Canc Ctr, Tumor Cell Biol Grp, Philadelphia, PA 19111 USA
关键词
D O I
10.1158/1078-0432.CCR-05-0684
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Telomeres are specialized nucleoprotein complexes that protect and confer stability upon chromosome ends. Loss of telomere function as a consequence of proliferation-associated sequence attrition results in genome instability, which may facilitate carcinogenesis by generating growth-promoting mutations. However, unlimited cellular proliferation requires the maintenance of telomeric DNA; thus, the majority of tumor cells maintain their telomeres either through the activity of telomerase or via a mechanism known as alternative lengthening of telomeres (ALT). Recent data suggest that constitutive telomere maintenance may not be required in all tumor types. Here we assess the role and requirement of telomere maintenance in liposarcoma. Experimental Design: Tumor samples were analyzed with respect to telomerase activity, telomere length, and the presence of ALT-specific subcellular structures, ALT-associated promyelocytic leukemia nuclear bodies. This multiassay assessment improved the accuracy of categorization. Results: Our data reveal a significant incidence (24%) of ALT-positive liposarcomas, whereas telomerase is used at a similar frequency (27%). A large number of tumors (49%) do not show characteristics of telomerase or ALT. In addition, telomere length was always shorter in recurrent disease, regardless of the telomere maintenance mechanism. Conclusions: These results suggest that approximately one half of liposarcomas either employ a novel constitutively active telomere maintenance mechanism or lack such a mechanism. Analysis of recurrent tumors suggests that liposarcomas can develop despite limiting or undetectable activity of a constitutively active telomere maintenance mechanism.
引用
收藏
页码:5347 / 5355
页数:9
相关论文
共 51 条
[1]   Constitutive telomerase expression promotes mammary carcinomas in aging mice [J].
Artandi, SE ;
Alson, S ;
Tietze, MK ;
Sharpless, NE ;
Ye, S ;
Greenberg, RA ;
Castrillon, DH ;
Horner, JW ;
Weiler, SR ;
Carrasco, RD ;
DePinho, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8191-8196
[2]   A critical role for telomeres in suppressing and facilitating carcinogenesis [J].
Artandi, SE ;
DePinho, RA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :39-46
[3]   Functional multimerization of the human telomerase reverse transcriptase [J].
Beattie, TL ;
Zhou, W ;
Robinson, MO ;
Harrington, L .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (18) :6151-6160
[4]   Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition [J].
Bechter, OE ;
Zou, Y ;
Walker, W ;
Wright, WE ;
Shay, JW .
CANCER RESEARCH, 2004, 64 (10) :3444-3451
[5]   Role of PML and the PML-nuclear body in the control of programmed cell death [J].
Bernardi, R ;
Pandolfi, PP .
ONCOGENE, 2003, 22 (56) :9048-9057
[6]   Evolving views of telomerase and cancer [J].
Blasco, MA ;
Hahn, WC .
TRENDS IN CELL BIOLOGY, 2003, 13 (06) :289-294
[7]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[8]  
Broccoli D, 1996, MOL CELL BIOL, V16, P3765
[9]   TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY [J].
BRYAN, TM ;
ENGLEZOU, A ;
GUPTA, J ;
BACCHETTI, S ;
REDDEL, RR .
EMBO JOURNAL, 1995, 14 (17) :4240-4248
[10]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274